HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Cyclin A immunocytology as a risk stratification tool for Barrett's esophagus surveillance.

AbstractPURPOSE:
Endoscopic surveillance of Barrett's esophagus (BE) by histopathologic biopsy assessment is suboptimal. A proliferation marker, minichromosome maintenance protein 2, has potential as a biomarker but lacks specificity. We hypothesized that cyclin A, which detects a proportion of proliferating cells, would be more specific. Because cytologic sampling has clinical advantages, we also evaluated the efficacy of cyclin A in endoscopic brushing samples.
EXPERIMENTAL DESIGN:
A cross-sectional cyclin A immunostaining study was done in 77 patients attending for BE surveillance and 17 patients undergoing evaluation of esophageal adenocarcinoma. The control tissues were as follows: 30 squamous esophagus, 20 gastric antrum, and 13 duodenum. A nested case-control study was done within the same surveillance cohort (16 progressors compared with 32 matched controls) to determine the relative risk for progression. Immunocytology was done for endoscopic brushings collected prospectively from 75 BE +/- dysplasia and 33 esophageal adenocarcinomas.
RESULTS:
Surface expression of cyclin A in BE samples correlated with the degree of dysplasia (P = 0.016). In the case-control cohort, patients with biopsies expressing cyclin A at the surface were more likely to progress to adenocarcinoma than those who did not (odds ratio, 7.5; 95% confidence interval, 1.8-30.7). The sensitivity and specificity of cyclin A expression in brushings for the detection of high-grade dysplasia and cancer patients were 97.8% and 58.7%, respectively. The associated negative predictive value was 97.4%.
CONCLUSIONS:
Cyclin A immunopositivity correlates with cancer risk. Application of this marker to endoscopic brushings could be used as a first step to identify BE patients with the highest risk of progression.
AuthorsPierre Lao-Sirieix, Laurence Lovat, Rebecca C Fitzgerald
JournalClinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 13 Issue 2 Pt 1 Pg. 659-65 (Jan 15 2007) ISSN: 1078-0432 [Print] United States
PMID17255290 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Cyclin A
Topics
  • Adenocarcinoma (diagnosis, metabolism)
  • Aged
  • Barrett Esophagus (diagnosis, metabolism)
  • Biomarkers, Tumor
  • Biopsy
  • Case-Control Studies
  • Cell Proliferation
  • Cohort Studies
  • Cyclin A (biosynthesis)
  • Disease Progression
  • Esophageal Neoplasms (diagnosis, metabolism)
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Mass Screening (methods)
  • Middle Aged
  • Risk
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: